Sign In
Buy ANGO
$12.78
-0.0150 (-0.117%)
At Close: Jul 13, 2026
AngioDynamics Earnings Calls
May 28, 2026
(Today)
| Release date | Jul 14, 2026 |
| EPS estimate | -$0.110 |
| EPS actual | - |
| Revenue estimate | 80.242M |
| Revenue actual | - |
| Expected change | +/- 13.99% |
Feb 28, 2026
-$0.0700 (36.36%)
| Release date | Apr 02, 2026 |
| EPS estimate | -$0.110 |
| EPS actual | -$0.0700 |
| EPS Surprise | 36.36% |
| Revenue estimate | 76.767M |
| Revenue actual | 78.421M |
| Revenue Surprise | 2.16% |
Nov 30, 2025
-$0.150 (-50.00%)
| Release date | Jan 06, 2026 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.150 |
| EPS Surprise | -50.00% |
| Revenue estimate | 76.435M |
| Revenue actual | 79.433M |
| Revenue Surprise | 3.92% |
Aug 31, 2025
-$0.100 (28.57%)
| Release date | Oct 02, 2025 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.100 |
| EPS Surprise | 28.57% |
| Revenue estimate | 76.312M |
| Revenue actual | 75.711M |
| Revenue Surprise | -0.788% |
Last 4 Quarters for AngioDynamics
Below you can see how ANGO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Aug 31, 2025
Beat
| Release date | Oct 02, 2025 |
| Price on release | $11.74 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.100 |
| EPS surprise | 28.57% |
| Date | Price |
|---|---|
| Sep 26, 2025 | $10.68 |
| Sep 29, 2025 | $10.74 |
| Sep 30, 2025 | $11.17 |
| Oct 01, 2025 | $11.07 |
| Oct 02, 2025 | $11.74 |
| Oct 03, 2025 | $11.64 |
| Oct 06, 2025 | $11.26 |
| Oct 07, 2025 | $11.05 |
| Oct 08, 2025 | $11.12 |
| 4 days before | 9.93% |
| 4 days after | -5.28% |
| On release day | -0.85% |
| Change in period | 4.12% |
Nov 30, 2025
Missed
| Release date | Jan 06, 2026 |
| Price on release | $11.44 |
| EPS estimate | -$0.100 |
| EPS actual | -$0.150 |
| EPS surprise | -50.00% |
| Date | Price |
|---|---|
| Dec 30, 2025 | $13.00 |
| Dec 31, 2025 | $12.84 |
| Jan 02, 2026 | $12.68 |
| Jan 05, 2026 | $13.23 |
| Jan 06, 2026 | $11.44 |
| Jan 07, 2026 | $10.92 |
| Jan 08, 2026 | $10.05 |
| Jan 09, 2026 | $9.86 |
| Jan 12, 2026 | $10.18 |
| 4 days before | -12.00% |
| 4 days after | -11.01% |
| On release day | -4.55% |
| Change in period | -21.69% |
Feb 28, 2026
Beat
| Release date | Apr 02, 2026 |
| Price on release | $10.31 |
| EPS estimate | -$0.110 |
| EPS actual | -$0.0700 |
| EPS surprise | 36.36% |
| Date | Price |
|---|---|
| Mar 27, 2026 | $10.90 |
| Mar 30, 2026 | $10.87 |
| Mar 31, 2026 | $11.37 |
| Apr 01, 2026 | $11.94 |
| Apr 02, 2026 | $10.31 |
| Apr 06, 2026 | $9.84 |
| Apr 07, 2026 | $9.70 |
| Apr 08, 2026 | $10.17 |
| Apr 09, 2026 | $10.09 |
| 4 days before | -5.41% |
| 4 days after | -2.13% |
| On release day | -4.56% |
| Change in period | -7.43% |
May 28, 2026
(Today)
| Release date | Jul 14, 2026 |
| Price on release | - |
| EPS estimate | -$0.110 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 07, 2026 | $13.07 |
| Jul 08, 2026 | $12.81 |
| Jul 09, 2026 | $12.92 |
| Jul 10, 2026 | $12.79 |
| Jul 13, 2026 | $12.78 |
AngioDynamics Earnings History
Earnings Calendar
FAQ
When is the earnings report for ANGO?
AngioDynamics (ANGO) has scheduled its earnings report for Jul 14, 2026 before the markets open.
What is the ANGO price-to-earnings (P/E) ratio?
ANGO P/E ratio as of Jul 13, 2026 (TTM) is -17.03.
What is the ANGO EPS forecast?
The forecasted EPS (Earnings Per Share) for AngioDynamics (ANGO) for the first fiscal quarter 2026 is -$0.110.
What are AngioDynamics's retained earnings?
On its balance sheet, AngioDynamics reported retained earnings of $0 for the latest quarter ending May 28, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
